New York city New Delhi Usa covid-19 medicines patient New York city New Delhi Usa

HCQ-Azithromycin raise risk of cardiac-death in covid-19 patients, shows study

Reading now: 750
www.livemint.com

NEW DELHI: The efficacy of hydroxychloroquine, the anti-malarial drug widely touted as the potential cure for covid-19, has come under further scrutiny.

It was found that covid-19 patients who were on a regimen of hydroxychloroquine (HCQ) and antibiotic azithromycin experienced irregular heartbeats, raising the risk of cardiac arrest in patients.

The findings emerged from a correspondence shared by researchers from the New York School of Medicine, US, who studied a cohort of 84 covid-19 patients admitted to the centre for treatment.

The findings were peer-reviewed and published in the journal Nature Medicine. They were shared in the backdrop of recent claims, which suggested that the drug combination could help patients diagnosed with

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA